CBSC (Cardiac Biotech Solutions) Dividend Yield %: 0.00% (As of Jul. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Cardiac Biotech Solutions Dividend Yield %?

Cardiac Biotech Solutions CBSC Dividend Yield % is 0.00% as of Jul. 14, 2026. Among 327 Medical Devices & Instruments companies, Cardiac Biotech Solutions ranks worse than 305810.09% on this metric.

As of today (2026-07-14), the Trailing Annual Dividend Yield of Cardiac Biotech Solutions is 0.00%.

The historical rank and industry rank for Cardiac Biotech Solutions's Dividend Yield % or its related term are showing as below:

CBSC's Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 1.91
* Ranked among companies with meaningful Dividend Yield % only.

Cardiac Biotech Solutions's Dividend Payout Ratio for the three months ended in Jun. 2025 was 0.00.

As of today (2026-07-14), the Forward Dividend Yield % of Cardiac Biotech Solutions is 0.00%.

Cardiac Biotech Solutions's Dividends per Share for the three months ended in Jun. 2025 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Cardiac Biotech Solutions  (OTCPK:CBSC) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Cardiac Biotech Solutions Dividend Yield % Related Terms

Cardiac Biotech Solutions Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Cardiac Biotech Solutions's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cardiac Biotech Solutions Dividend Yield % Chart

Cardiac Biotech Solutions Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Dividend Yield %
0.00 0.00 0.00 0.00 0.00

Cardiac Biotech Solutions Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Mar25 Jun25
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

CBSC vs LUCY, NXGL, MHUAF: Dividend Yield % Comparison

For the Medical Instruments & Supplies subindustry, Cardiac Biotech Solutions's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cardiac Biotech Solutions Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cardiac Biotech Solutions's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Cardiac Biotech Solutions's Dividend Yield % falls into.


Cardiac Biotech Solutions Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 0.00% mean?
Cardiac Biotech Solutions (CBSC) has a Dividend Yield % of 0.00% as of Jul. 14, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Cardiac Biotech Solutions and its competitors. According to the industry distribution chart, Cardiac Biotech Solutions ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is Cardiac Biotech Solutions' Dividend Yield % too high?
Cardiac Biotech Solutions' current Dividend Yield % is 0.00%. Based on the distribution chart, Cardiac Biotech Solutions ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Cardiac Biotech Solutions' Dividend Yield % compare to LUCY and NXGL?
According to the Medical Devices & Instruments industry distribution chart, Cardiac Biotech Solutions ranks #999999 out of 327 companies for Dividend Yield %. This places Cardiac Biotech Solutions in the lower half of its industry. The industry median Dividend Yield % is 1.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.91, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Cardiac Biotech Solutions and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cardiac Biotech Solutions's current Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cardiac Biotech Solutions stock overvalued right now?
Cardiac Biotech Solutions (CBSC) has a current Dividend Yield % of 0.00%. The current Dividend Yield % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Cardiac Biotech Solutions (CBSC), the current Dividend Yield % is 0.00% as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cardiac Biotech Solutions Business Description

Address 10845 Griffith Peak Drive, Suite 200, Las Vegas, NV, USA, 89135
Cardiac Biotech Solutions Inc, through its U.S. and international subsidiaries, provides products and services in the ambulatory non-invasive cardiac monitoring space. The FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.